TAIRX INC has a total of 29 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2011. It filed its patents most often in Republic of Korea, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are EISAI R & AMP D MAN CO LTD, GUILFORD PHARM INC and GLAXOSMITHKLINE IP NO 2 LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 5 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | Brazil | 3 | |
#6 | United States | 3 | |
#7 | Japan | 2 | |
#8 | Russian Federation | 2 | |
#9 | Taiwan | 2 | |
#10 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Special acyclic compounds | |
#4 | Heterocyclic compounds | |
#5 | Peptides | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Chien Du-Shieng | 10 |
#2 | Chu Yi-Wen | 10 |
#3 | Chou Li-Chen | 7 |
#4 | Chung Jing-Gung | 6 |
#5 | Lee Kuo-Hsiung | 6 |
#6 | Wu Tian-Shung | 6 |
#7 | Huang Chi-Hung | 6 |
#8 | Kuo Sheng-Chu | 6 |
#9 | Yang Jai-Sing | 6 |
#10 | Way Tzong-Der | 6 |
Publication | Filing date | Title |
---|---|---|
US2020239561A1 | Nodal regulation of cancer drug resistance gene | |
CA3049125A1 | Compositions for use in treating inflammatory bowel diseases and intestinal colitis | |
US2016354361A1 | Use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry | |
KR20170118244A | Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives |